Fig. 1 · Structure
Documents & Downloads
Cenacitinib
Janus Kinase Inhibitor
Cenacitinib is a potent Janus kinase inhibitor that modulates the activity of critical signaling pathways involved in inflammatory responses. This compound exhibits significant anti-inflammatory activity, making it valuable for research applications in treating autoimmune diseases and other inflammatory conditions. Its ability to specifically target Janus kinases positions it as a promising tool for studying cytokine signaling and immune regulation.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 2641636-52-2 |
| Applications | Janus Kinase Inhibitor |
| Formula | C19H19F2N7O3 |
| Molecular Weight | 431.40 |
| SMILES | F[C@@H](C1)[C@@H]1NC(NC2=C3N(N=C2)C(NC)=CC(NC4=C5C(OCCO5)=CC(F)=C4)=N3)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.